PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCRζ expression but are functionally impaired

Journal of Immunotherapy

Volumn 21, Issue 4, 1998, Pages 317-

  Nieland, John D ^a   Loviscek, Kathleen ^a   Kono, Koji ^b   Albain, Kathy S ^a   McCall, Anne R ^a   Potkul, Ronald K ^a   Fisher, Susan G ^a   Velders, Markwin P ^a   Petersson, Max ^c   Kiessling, Rolf ^a   Martin Kast, W ^a  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast carcinoma; Cervical carcinoma; Natural killer cell; T cell; chain

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 10; RECEPTOR SUBUNIT; T LYMPHOCYTE RECEPTOR;

BREAST CARCINOMA; CANCER GRADING; CONFERENCE PAPER; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE; UTERINE CERVIX CARCINOMA;

BREAST NEOPLASMS; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; MEMBRANE PROTEINS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IGG; T-LYMPHOCYTES; UTERINE CERVICAL NEOPLASMS;

EID: 0031847641     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199807000-00009     Document Type: Article

References (22)

1. Zier K, Gansbacher B, Salvadori S. Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy. Immunol Today 1996;17:39-45.
2. Levey DL, Srivastava PK. T cells from late tumor-bearing mice express normal levels of p561ck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity. J Exp Med 1995;182:1029-36.
3. Zea AH, Curti BD, Longo DL, et al. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res 1995;1:1327.
4. Finke JH, Zea AH, Stanley J, et al. Loss of T-cell receptor zeta chain and p561ck in T-cells infiltrating human renal cell carcinoma. Cancer Res 1993;53:5613-6.
5. Tartour E, Latour S, Mathiot C, et al. Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer 1995;63:205-12.
6. Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 1996;2:161-73.
7. Matsuda M, Petersson M, Lenkei R, et al. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer 1995;61:765-72.
8. Nakagomi H, Petersson M, Magnusson I, et al. Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 1993;53:5610-2.
9. Kono K, Ressing ME, Brandt RMP, et al. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 1996;2: 1825-8.
10. Kono K, Salazar-Onfray F, Petersson M, et al. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity. Eur J Immunol 1996;26: 1308-13.
11. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996;335:865-75.
12. De Flora S, D’Agostini F, Masiello L, Giunciuglio D, Albini A. Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models. Int J Cancer 1996;67:842-8.
13. Wang Y, Huang DS, Liang B, Watson RR. Nutritional status and immune responses in mice with murine AIDS are normalized by vitamin E supplementation. J Nutr 1994;124:2024-32.
14. Hahne M, Rimoldi D, Schroter M, et al. Melanoma cell expression of FAS(APO-l/CD95) ligand-implications for tumor immune escape. Science 1996;274:1363-6.
15. Wang Q, Stanley J, Kudoh S, et al. T cells infiltrating non-Hodgkin’s B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. J Immunol 1995;155:1382-92.
16. O’Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 1994;6:458-66.
17. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH. Differential ability of Thl and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 1994;6:1545-53.
18. Combadiere B, Freedman M, Chen L, Shores EW, Love P, Lenardo MJ. Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis. J Exp Med 1996; 183:2109-17.
19. Labadia ME, Ingraham RH, Schembri-King J, Morelock MM, Jakes S. Binding affinities of the SH2 domains of ZAP-70, p561ck and She to the zeta chain ITAMs of the T-cell receptor determined by surface plasmon resonance. J Leukocyte Biol 1996;59:740-6.
20. Sher A, Gazzinelli RT, Oswald IP, et al. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 1992;127:183-204.
21. Hahn S, Gehri R, Erb P. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 1995;146:57-79.
22. Yagita H, Hanabuchi S, Asano Y, Tamura T, Nariuchi H, Okumura K. Fas-mediated cytotoxicity-a new immunoregulatory and pathogenic function of Thl CD4+ T cells. Immunol Rev 1995;146: 223-39.